−124.2971 CAD
−69.11 M CAD
0.00 CAD
2.14 M
About Aptose Biosciences, Inc.
Sector
CEO
William G. Rice
Headquarters
Toronto
Website
Founded
1986
FIGI
BBG00JVRKXM5
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0UI8 is 7.6575 CAD — it has decreased by −80.81% in the past 24 hours. Watch APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) stocks are traded under the ticker 0UI8.
0UI8 reached its all-time high on Mar 24, 2021 with the price of 1,669.5000 CAD, and its all-time low was 0.2552 CAD and was reached on Nov 25, 2024. View more price dynamics on 0UI8 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0UI8 stock is 421.06% volatile and has beta coefficient of −2.69. Track APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) stock price on the chart and check out the list of the most volatile stocks — is APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) there?
Today APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) has the market capitalization of 16.41 M, it has decreased by −46.00% over the last week.
Yes, you can track APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) financials in yearly and quarterly reports right on TradingView.
0UI8 net income for the last quarter is −9.48 M CAD, while the quarter before that showed −9.92 M CAD of net income which accounts for 4.42% change. Track more APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) financial stats to get the full picture.
No, 0UI8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 2, 2025, the company has 35.00 employees. See our rating of the largest employees — is APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) on this list?
Like other stocks, 0UI8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) stock shows the sell signal. See more of APTOSE BIOSCIENCES INC COM NPV (POST REV SPT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.